New scan could reveal hidden cancer spread in breast cancer patients
NCT ID NCT07314073
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a special type of PET scan (called FES PET/CT) to see if it can better find cancer that has spread to other parts of the body in people with a certain type of breast cancer. The study includes 85 adults with low-grade, estrogen receptor-positive stage III breast cancer. The goal is to improve detection of distant metastases, which could help guide treatment decisions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE III BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Asan Medical Center
RECRUITINGSeoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug combo shows promise against hereditary breast cancer
- Acupuncture needles aim to zap cancer brain fog
- Blood test catches cancer early: new drug aims to stop spread
- New drug cocktail aims to wipe out breast cancer before surgery
- New hope for Hard-to-Treat breast cancer: immune cocktails enter trial
- Can acupuncture soothe Chemo's nerve pain? small study hints yes